National Bank of Canada’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-38
Closed -$1.61K 3210
2024
Q3
$1.61K Buy
+38
New +$1.61K ﹤0.01% 2375
2024
Q1
Sell
-3
Closed -$85 2914
2023
Q4
$85 Sell
3
-40
-93% -$830 ﹤0.01% 2664
2023
Q3
$945 Sell
43
-20
-32% -$549 ﹤0.01% 2597
2023
Q2
$1.54K Sell
63
-141
-69% -$4.54K ﹤0.01% 2503
2023
Q1
$8.28K Hold
204
﹤0.01% 2189
2022
Q4
$9.16K Sell
204
-556
-73% -$25.2K ﹤0.01% 2207
2022
Q3
$36K Sell
760
-145
-16% -$7.95K ﹤0.01% 1814
2022
Q2
$54K Sell
905
-236
-21% -$19.4K ﹤0.01% 1749
2022
Q1
$133K Buy
1,141
+113
+11% +$13.2K ﹤0.01% 1598
2021
Q4
$155K Buy
+1,028
New +$139K ﹤0.01% 1525

Other funds holding TNDM

National Bank of Canada's TNDM Position: Q4 2024 in Review

National Bank of Canada sold out of Tandem Diabetes Care (TNDM) in Q4 2024, closing a stake of 38 shares — an estimated $1.61K sold.

National Bank of Canada first reported a position in TNDM in Q4 2021 and held it in 10 quarters. The position peaked at $155K in Q4 2021. 316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

  • National Bank of Canada reported no remaining Tandem Diabetes Care position as of Q4 2024 after selling out during the quarter.
  • National Bank of Canada sold 38 Tandem Diabetes Care shares in Q4 2024, an estimated $1.61K.
  • National Bank of Canada first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 10 quarters.
  • National Bank of Canada's Tandem Diabetes Care position peaked at $155K in Q4 2021.
  • 316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on National Bank of Canada's 13F filing for Q4 2024, filed 12 Feb 2025.